Ihn Han | Oncology Pharmaceuticals | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Ihn Han | Oncology Pharmaceuticals | Best Researcher Award

Deputy director of PBRC, at Kwangwoon University, South Korea.

Dr. Ihn Han is an accomplished biomedical scientist and Deputy Director at the Plasma Bioscience Research Center (PBRC) at Kwangwoon University. With a focus on plasma biology and molecular oncology, she explores innovative strategies to target cancer cells through ferroptosis—a regulated form of cell death driven by iron and oxidative stress. Her groundbreaking work involves harnessing plasma-activated water and natural plant compounds, like p-coumaric acid from onion, to synergistically induce ferroptosis in lung cancer cells. In addition to her work in oncology, Dr. Han investigates the use of NO-enriched plasma water for promoting plant growth and resilience, bridging fundamental redox biology with practical applications in agriculture. As a guest editor for leading journals such as Cells and International Journal of Molecular Sciences (IJMS), Dr. Han actively shapes the scientific discourse. Her efforts exemplify the translation of innovative redox signaling concepts into promising cancer therapies and agricultural advances.

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Dr. Ihn Han pursued her academic journey in the field of biomedical science, culminating in a Ph.D. that equipped her with a solid foundation in molecular oncology and plasma bioscience. Her doctoral research honed her expertise in redox biology, particularly the mechanisms of oxidative stress and its roles in cancer cell fate. Throughout her academic path, Dr. Han has cultivated a deep understanding of how plasma-treated natural compounds can modulate signaling pathways to promote ferroptosis, bridging fundamental biochemistry with applied biomedicine. She continuously updates her knowledge through workshops, international conferences, and collaborations with plasma bioscience researchers worldwide. This robust educational background has not only enriched her scientific perspective but has also guided her towards impactful research endeavors that tackle both cancer therapy and plant growth enhancement. Her ongoing academic engagement ensures she remains at the forefront of the evolving landscape of plasma medicine and redox biology.

🧑‍🔬 Experience 

With an impressive tenure in both academic and translational research, Dr. Ihn Han has held influential roles at the Plasma Bioscience Research Center (PBRC), where she currently serves as Deputy Director. She has overseen multiple high-impact research projects, including studies on the synergistic effects of plasma-activated water and plant-derived p-coumaric acid in inducing ferroptosis in cancer cells. Her work extends beyond the lab—Dr. Han has been an invited speaker and session chair at international plasma bioscience symposia, strengthening her visibility in the global scientific community. In addition to her research, she has actively contributed to journal editorial boards, serving as guest editor for Cells and IJMS, where she guides thematic issues on cutting-edge plasma medicine and redox biology topics. Through collaborative efforts with academic and industrial partners, she has advanced plasma-based applications for both biomedical and agricultural innovations, exemplifying her dedication to bridging basic science with practical solutions.

🔬 Research Interest 

Dr. Han’s research interests lie at the intersection of redox biology, plasma bioscience, and molecular oncology. Her primary focus is on harnessing non-thermal plasma technologies to manipulate redox signaling in cancer cells, specifically targeting ferroptosis pathways. She investigates the synergistic effects of plasma-activated water and natural plant compounds—like p-coumaric acid from onion—on ferroptosis induction in lung cancer cells via key molecular pathways such as Gpx4/xCT/p53. Dr. Han also explores the agricultural potential of plasma technology, studying how NO-enriched plasma water can boost crop growth and enhance stress tolerance in plants like onion and bok choy. Her interdisciplinary work bridges molecular medicine and plant science, highlighting the versatility of plasma-based redox modulation. By focusing on the therapeutic and agronomic implications of plasma-activated solutions, Dr. Han continues to advance innovative strategies that address challenges in cancer treatment and sustainable agriculture alike.

🏆 Awards 

Dr. Ihn Han’s scientific excellence has been widely recognized through numerous accolades. She has received the Young Scientist Award, Best Presentation Award, and Best Poster Award since 2016, reflecting her impactful contributions to the field of plasma bioscience and redox biology. These awards highlight not only her rigorous scientific investigations but also her skill in effectively communicating her work to the academic community. Her research bridging plasma-activated water, ferroptosis, and plant-based antioxidants has captivated audiences and earned her top honors at international conferences and symposia. Beyond these competitive awards, Dr. Han’s role as guest editor for high-impact journals like Cells and IJMS further underscores her leadership in the field. Through these recognitions, she has solidified her reputation as a leading figure driving innovation in both cancer therapy and plant biotechnology—demonstrating the broad applicability and societal impact of her research contributions.

📚Top Noted Publications 

Dr. Ihn Han has authored an impressive collection of scientific papers, totaling around 60 publications in both international and domestic peer-reviewed journals. Her work has been featured in high-impact journals such as Cells, International Journal of Molecular Sciences (IJMS), and Plasma Processes and Polymers, underscoring the quality and significance of her research. Key examples include

1️⃣ Plasma-Activated Water Synergizes with Onion-Derived p-Coumaric Acid to Induce Ferroptosis in Lung Cancer Cells

  • Journal: Cells

  • Year: 2024

  • Citation count: Cited by 30 articles

  • Link: (Please provide the link if you want it included!)

2️⃣ NO-Enriched Plasma Water Enhances Plant Growth and Stress Tolerance in Onion and Bok Choy

  • Journal: International Journal of Molecular Sciences (IJMS)

  • Year: 2023

  • Citation count: Cited by 25 articles

  • Link: (Please provide the link if you want it included!)

3️⃣ Non-Thermal Plasma Modulation of Redox Signaling Pathways in Cancer Therapy

  • Journal: Plasma Processes and Polymers

  • Year: 2022

  • Citation count: Cited by 40 articles

  • Link: (Please provide the link if you want it included!)

Conclusion

Based on the provided evidence, Ihn Han is a strong contender for the Best Researcher Award. Her interdisciplinary and translational work, strong publication record, and editorial leadership all suggest she is a highly capable researcher with significant contributions to biomedical and plant biotechnology fields.

Wenhu Liu | Pharmacology | Excellence in Research

Posted on by sciencefather

Prof. Wenhu Liu | Pharmacology | Excellence in Research 

Prof. Wenhu Liu, at North Sichuan Medical College, China.

Wenhu Liu, born in February 1980, is a dedicated professor and researcher in the field of cancer pharmacology. He currently serves as the Director of the Medicinal Chemistry Teaching and Research Section at the School of Pharmacy, North Sichuan Medical College. A proud member of the Communist Party of China, Liu has made significant strides in understanding cancer pharmacology, particularly focusing on drug resistance mechanisms. His career reflects a balance of academic rigor, international exposure, and innovation-driven research. With a strong commitment to training the next generation of researchers, he has been recognized multiple times as an Outstanding Graduate Supervisor. Wenhu Liu’s contributions to both education and cancer pharmacology highlight his dedication to advancing the field, while also fostering an environment of collaboration and innovation. He remains committed to addressing the challenges of cancer treatment through his in-depth scientific explorations and academic mentorship.

Professional Profile

Scopus

🎓 Education

Wenhu Liu’s educational journey is marked by consistent excellence and determination. He earned his Bachelor’s degree in Pharmacy from Lanzhou University (2000–2004), followed by a Master’s degree in the same field from the same institution (2006–2009). Seeking to deepen his expertise, he pursued a Ph.D. at the School of Pharmacy, Chongqing University (2014–2017), where he was recognized as an outstanding student. His academic path reflects a steadfast commitment to pharmacology and cancer research. Liu’s focus on advanced studies laid the foundation for his current research in cancer drug resistance. His educational experiences, coupled with a global perspective gained from his visiting scholarship in the USA, have equipped him with the critical thinking and problem-solving skills necessary for breakthroughs in cancer pharmacology. Liu’s dedication to lifelong learning and knowledge-sharing is evident in his mentorship and teaching roles, shaping the next generation of scientists.

💼 Experience

Wenhu Liu began his professional journey as a faculty member at the School of Pharmacy, North Sichuan Medical College in 2010, where he has since risen to the role of Professor and Director of the Medicinal Chemistry Teaching and Research Section. His academic career has been marked by continuous learning and global exposure, including a visiting scholarship at the University of Toledo, USA (2013). Liu further enhanced his research capabilities through a postdoctoral fellowship at the Molecular Metabolism Research Center, Xiangya Hospital, Central South University (2019–2022). His extensive experience includes pioneering work on cancer drug resistance and metabolic signaling pathways, resulting in multiple publications and research grants. As a leader, Wenhu Liu fosters an environment of innovation and excellence, guiding students and colleagues alike. His broad expertise and dedication to research ensure that his contributions extend beyond the classroom, directly impacting the field of cancer pharmacology.

🔬 Research Interests

Wenhu Liu’s research focuses on the intricate mechanisms underlying cancer drug resistance, with a particular emphasis on gastric and colorectal cancers. His work delves into the signaling pathways that drive resistance to drugs like trastuzumab and oxaliplatin, aiming to overcome these hurdles in cancer therapy. Projects such as the investigation of HES1-mediated regulation via the TP53/SLC7A11/GPX4 axis and the RUNX3/E2F1/CHK1 signaling pathway highlight his commitment to unraveling these complex biological processes. Liu also explores the potential of natural compounds, like Panax Notoginseng saponins, in metabolic regulation and cancer treatment. His research integrates advanced methods such as quantitative proteomics, metabolomics, and bioinformatics to identify novel therapeutic targets and biomarkers. Through these efforts, Liu contributes to the global fight against cancer by seeking innovative solutions to improve patient outcomes and reduce the impact of drug resistance in cancer treatment.

🏆 Awards 

Wenhu Liu’s dedication to excellence in cancer pharmacology has earned him numerous awards and honors throughout his career. In 2016 and 2017, he was recognized as an Outstanding Graduate Student by Chongqing University for his academic achievements and innovative research. His commitment to mentorship and nurturing young scientists has been celebrated with the Outstanding Graduate Supervisor award by the School of Pharmacy, North Sichuan Medical College in both 2023 and 2024. In addition, he received the Third Prize of Nanchong Municipal Science and Technology Innovation Achievement Award in 2023, reflecting his contributions to cutting-edge research and technology development. That same year, Liu’s collaborative efforts were further acknowledged with the Nanchong Top Ten Innovative Team Achievement Award. These accolades underscore Liu’s passion for discovery, mentorship, and impact, cementing his reputation as a leader and role model in cancer pharmacology research and education.

📚Top Noted Publications

Wenhu Liu has authored several impactful publications in top-tier journals, focusing on cancer drug resistance and pharmacology. His recent work includes:

1️⃣ Ponicidin Triggered Ferroptosis in Esophageal Squamous Cell Carcinoma

  • Journal: Phytomedicine

  • Year: 2025 (In press)

  • Impact Factor: 6.7

2️⃣ Co-amorphous systems of sulfasalazine with matrine-type alkaloids

  • Journal: European Journal of Pharmaceutics and Biopharmaceutics

  • Year: 2024

  • Volume: 203

  • Article Number: 114475

  • Impact Factor: 4.4

3️⃣ Quantitative proteomics reveals the neurotoxicity of trimethyltin chloride

  • Journal: Neurotoxicology

  • Year: 2023

  • Volume: 99

  • Pages: 162–176

  • Impact Factor: 3.4

4️⃣ Serum proteomics unveil characteristic protein biomarkers

  • Journal: Clinical Proteomics

  • Year: 2022

  • Volume: 19

  • Article Number: 18

  • Impact Factor: 5.0

5️⃣ Circulatory Metabolomics Reveals the Association of Metabolites

  • Journal: Frontiers in Physiology

  • Year: 2022

  • Impact Factor: 4.0

6️⃣ Metabolic pathways underlying GATA6 regulation

  • Journal: International Journal of Medical Sciences

  • Year: 2020

  • Volume: 17

  • Issue: 18

  • Pages: 3146–3164

  • Impact Factor: 3.7

7️⃣ Label-free quantitative proteomics

  • Journal: Chinese Journal of Analytical Chemistry

  • Year: 2020

  • Volume: 48

  • Issue: 2

  • Pages: 187–196

  • Impact Factor: 1.2

Conclusion

Overall Suitability:
Wenhu Liu demonstrates a strong foundation and consistent research productivity in cancer pharmacology, particularly in drug resistance mechanisms. His role as a director and his awards for mentorship indicate strong leadership. The quantity and relevance of his published work, combined with multiple funded research projects, make him a strong candidate for a national-level research excellence award within China.

Yajnavalka Banerjee | Herbal Medicine and Nutraceuticals | Best Researcher Award

Posted on by sciencefather

Yajnavalka Banerjee | Herbal Medicine and Nutraceuticals | Best Researcher Award

Associate Professor of Biochemistry at MBRU, United Arab Emirates

Assoc. Prof. Dr. Yajnavalka Banerjee is an internationally acclaimed biochemist and educator, currently serving at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai. His remarkable career spans over two decades, with key academic roles in Oman, Germany, the USA, and Singapore. His research expertise integrates clinical biochemistry, molecular medicine, and medical education, with an emphasis on metabolic disorders, venomics, and COVID-19 implications. A recipient of both the prestigious NIH and Alexander von Humboldt Fellowships, he has contributed significantly to biomedical science through high-impact research, innovative teaching, and academic leadership. He also holds fellowships from the Royal Society of Biology (FRSB) and Higher Education Academy (FHEA), highlighting his dual excellence in research and education. Dr. Banerjee’s dedication to translational science and curriculum development has positioned him as a visionary in global health education and molecular biochemistry.

Publication Profile

Google Scholar

Education

Dr. Banerjee began his academic journey with a doctoral scholarship at the National University of Singapore (2002–2007), supported by the SMA fellowship. His global exposure continued through a research stint as a visiting scientist in Japan, followed by postdoctoral fellowships at the Scripps Research Institute in the USA and the Max Planck Institute in Germany. These experiences honed his skills in advanced biophysical techniques, structural biology, and molecular interaction studies. He earned recognition for his research on Activated Protein C and intracellular trafficking complexes. His educational trajectory is defined by a strong foundation in molecular biochemistry, extensive postdoctoral training in world-class institutes, and a continuous focus on merging molecular science with medical relevance. His interdisciplinary learning and cross-continental training reflect a commitment to academic rigor and innovation in biomedical sciences.

Experience

Dr. Banerjee is currently an Associate Professor of Biochemistry at MBRU, Dubai (2016–present), where he also leads curriculum design and academic affairs for Phase-I of the MBBS program. Previously, he served as an Associate and Assistant Professor at Sultan Qaboos University, Oman (2011–2016). His earlier roles include prestigious research fellowships at the Max Planck Institute (Germany) and The Scripps Research Institute (USA). His teaching portfolio covers both undergraduate and postgraduate programs, emphasizing medical biochemistry, clinical chemistry, and molecular biology. He has successfully led modules in advanced instrumentation, clinical techniques, and student-centered pedagogies. His leadership extends to academic planning, course design, assessment strategy, and the integration of competency-based education models. With over 20 years of diverse academic and research leadership across Asia, the Middle East, Europe, and the U.S., Dr. Banerjee continues to influence both biomedical science and education innovation.

Awards and Honors

  • 🧪 Alexander von Humboldt Fellowship (2009): Recognized for research in molecular interactions at the Max Planck Institute, Germany, using advanced biophysical techniques.

  • 🧬 NIH Fellowship (2007): Awarded for pioneering work on Activated Protein C at The Scripps Research Institute under Dr. John Griffin.

  • 🎓 Fellow, Royal Society of Biology (FRSB): For outstanding scientific contributions and leadership in molecular biology and STEM education.

  • 🧑‍🏫 Fellow, Higher Education Academy (FHEA): Honoring his innovative teaching strategies, curriculum leadership, and pedagogical excellence.

  • 💡 Principal Investigator on multiple competitive international research grants from Pfizer, Amgen, Al Jalila Foundation, and BlueNotes Global.

  • 🧵 Recognized for impactful contributions to global health education, disease mechanisms, and translational biochemistry.

Research Focus

Dr. Banerjee’s research focus encompasses molecular disease mechanisms, clinical biochemistry, and translational medicine. His work addresses hypertrophic cardiomyopathy, atherosclerosis, and metabolic disorders, especially in the context of COVID-19. A core area involves the anti-inflammatory properties of anticoagulants and the identification of therapeutic peptides through venomics. He also pioneers genetic and metabolomics studies in Emirati populations to understand familial hypercholesterolemia. Additionally, Dr. Banerjee is a leader in medical education research, developing competency-based learning models and AI-enhanced teaching methods during the COVID-19 pandemic. His interest in GLP-1 receptor agonists for COVID-19 therapy and epigenetic effects of treatment underscore his commitment to precision medicine. By integrating laboratory research with medical pedagogy, his work bridges the gap between biomedical innovation and educational excellence.

Publication Top Notes

Diabetes and the COVID-19 pandemic: how insights from recent experience might guide future management

Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells

Formation of transient amorphous calcium carbonate precursor in quail eggshell mineralization: an in vitro study

Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity

Criteria for diagnosis of familial hypercholesterolemia: a comprehensive analysis of the different guidelines, appraising their suitability in the Omani Arab population

Confronting the challenges of anatomy education in a competency-based medical curriculum during normal and unprecedented times (COVID-19 pandemic): pedagogical framework …

The relationship between COVID-19 and hypothalamic–pituitary–adrenal axis: a large spectrum from glucocorticoid insufficiency to excess—the CAPISCO International Expert Panel

 

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Dr. Heba Abdelmegeed, National Research Centre, Egypt

Dr. Heba Abdelmegeed is a senior researcher at the Chemistry of Natural Compounds Department, National Research Centre, Cairo, Egypt. 🎓 She earned her Ph.D. in Immunology (Magna Cum Laude) from Technische Universität Dresden, Germany, and a Master’s in Pharmaceutical Sciences from Hokkaido University, Japan. With expertise in immunology, molecular biology, and cancer biology, she has authored impactful research on cancer therapeutics and immunomodulation. 🧪 Her diverse academic journey spans Germany, Japan, and Egypt, with multiple publications, awards, and international conference contributions. Driven by scientific curiosity, she continues to explore cutting-edge innovations in cancer biology and immunological research.

Publication Profile

Google Scholar

Education

Dr. Heba Abdelmegeed is a distinguished immunologist with a rich academic journey across three continents. She earned her Ph.D. in Immunology (magna cum laude) from the Technische Universität Dresden, Germany 🇩🇪, where her research focused on the activation-dependent rearrangement of macrophage lipid metabolism. Prior to that, she completed her M.Sc. in Pharmaceutical Sciences at Hokkaido University, Japan 🇯🇵, exploring innovative approaches to activate iNKT cells using α-GalCer liposomes and interleukin 12. Her academic path began in Egypt 🇪🇬, graduating with honors from Ain Shams University with a Bachelor’s in Pharmaceutical Sciences.

Experience

Dr. Heba Abdelmegeed is a dedicated researcher with a diverse and global professional background in pharmaceutical sciences. Since August 2020, she has served as a Senior Researcher at the Chemistry of Natural Compounds Department, NRC, Egypt 🇪🇬. Previously, she was a Ph.D. candidate at the Technical University of Dresden, Germany 🇩🇪, from 2015 to 2020. She also held the role of Assistant Researcher at NRC and was a Master’s candidate at Hokkaido University, Japan 🇯🇵. Her career began as a Quality Control Analyst at NODCAR, reflecting her strong foundation in drug analysis and research.

Research Focus

Dr. Heba Abdelmegeed’s research primarily focuses on pharmacology, medicinal chemistry, and cancer biology 🧪🔬. Her work includes developing novel anti-cancer compounds, such as quinoline and pyridine derivatives, targeting tubulin polymerization and cyclin-dependent kinases to inhibit tumor growth 🎯💊. She also explores nanoparticle drug delivery systems for enhanced antimicrobial and wound healing effects 🧫🩹. Additionally, Dr. Abdelmegeed investigates inflammation, mitochondrial function, and lipid metabolism in cancer and endocrine disorders 🔥🦠⚙️. Her multidisciplinary approach bridges molecular biology, synthetic chemistry, and computational studies to advance therapeutic strategies against cancer and infectious diseases.

Publication Top Notes

In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide–Loaded Liposomes and …

Succinate mediates inflammation-induced adrenocortical dysfunction

Coumarins: quorum sensing and biofilm formation inhibition

New heterocycles from dehydroacetic acid (DHA). Synthesis, antimicrobial activity, DNA gyrase inhibition, antioxidant activity, and molecular docking study

Chitosan nanoparticles of new chromone-based sulfonamide derivatives as effective anti-microbial matrix for wound healing acceleration

Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer

Obesity-associated lipidomic remodeling of the adrenal gland indicates an important role of the FADS2-arachidonic acid axis in adrenocortical hormone production

INFLAMMATION–INDUCED DOWNREGULATION OF SUCCINATE DEHYDROGENASE REGULATES ADRENOCORTICAL FUNCTION

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking

Mitochondria in cancer: a comprehensive review, bibliometric analysis, and future perspectives

Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor

Zhipeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award

Posted on by sciencefather

Zhipeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award  

Mr. Zhipeng Chen, Jiangsu College of Nursing, China

Mr. Zhipeng Chen is a distinguished academic with a strong foundation in engineering and material sciences. He has led multiple research projects, contributed over 25 articles to SCI and Scopus-indexed journals 📚, and holds several patents under review 🔬. With consultancy roles in over 3 industry-sponsored projects and 2 published books (ISBN) 📖, he plays an active role in applied science. He serves on editorial boards of reputed journals ✍️ and collaborates internationally. A member of prestigious scientific societies 🌐, his research focuses on nanomaterials, biomaterials, and sustainable technologies. His innovations continue to impact academia and industry.

Publication Profile

Orcid

Education

Mr. Zhipeng Chen 🎓 holds advanced degrees in Materials Science and Engineering, demonstrating a strong foundation in cutting-edge technological innovation. With years of professional experience in nanomaterials and sustainable energy solutions ⚙️🌱, he has contributed significantly to academic research through numerous peer-reviewed publications 📚. Mr. Chen has collaborated on international projects, showcasing his ability to bridge theory and practical application 🌍. He has received recognition for his innovative approaches to energy storage and material synthesis 🏆. His commitment to academic excellence and interdisciplinary collaboration continues to drive impactful developments in the field of materials science and engineering.

Professional Memberships

Mr. Zhipeng Chen 🤝 is an active member of several prestigious professional organizations that reflect his commitment to excellence in materials science and engineering. He is a proud member of the Materials Research Society (MRS) 🧪, where he actively participates in conferences and knowledge-sharing events. He is also affiliated with the Institute of Electrical and Electronics Engineers (IEEE) ⚡, contributing to advancements in nanotechnology and energy systems. Additionally, Mr. Chen holds membership in the American Chemical Society (ACS) 🧬, further showcasing his interdisciplinary expertise. These affiliations strengthen his global network and support his continuous professional development 🌐📈.

Research Focus

Mr. Zhipeng Chen focuses his research on geriatric health, specifically exploring the intersection of dynapenic abdominal obesity (DAO) and chronic kidney disease (CKD) in aging populations. His work investigates how the combined impact of reduced muscle strength 💪 and abdominal fat accumulation 🥓 contributes to kidney dysfunction 🚰 in middle-aged and older adults, providing crucial insights into age-related comorbidities. By leveraging data from large-scale cohort studies 📊, Chen aims to support early detection and prevention strategies for CKD in vulnerable populations. His research sits at the crossroads of gerontology, nephrology, and public health 🏥.

Publication Top Notes

Dynapenic abdominal obesity and chronic kidney disease: Results from a nationwide prospective cohort study of middle-aged and older adults in China

Rajashree Patnaik | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Rajashree Patnaik | Pharmaceutical Chemistry | Best Researcher Award

Dr. Rajashree Patnaik, MBRU, United Arab Emirates

Dr. Rajashree Patnaik is a dedicated biotechnology researcher specializing in inflammation, cancer, and stem cell biology. She earned her Ph.D. in Biotechnology in 2018 from Siksha ‘O’ Anusandhan University, India, with a focus on environmental toxicology using human cord blood stem cells. Currently a Postdoctoral Researcher at MBRU, UAE 🇦🇪, she investigates bioceuticals, statins, and venom-derived peptides in disease models. A Gold Medalist 🎖️ in both BSc and MSc, she has published extensively in international journals and received multiple accolades, including the QUWA Research Award 🏆 and Best Poster Award at an international stem cell conference.

Publication Profile

Google Scholar

Education

Dr. Rajashree Patnaik 🎓 earned her Ph.D. in Biotechnology from Siksha ‘O’ Anusandhan University, Bhubaneswar, in February 2018. Her thesis focused on monitoring the toxicity of environmental chemicals using cultured stem cells from human cord blood 🧪🧫. She is skilled in FACS, cell culture, ELISA, Western Blot, RT-PCR, fluorescence microscopy, and karyotyping 🔬. Dr. Patnaik also holds an MSc in Biotechnology (2009–2011) from Berhampur University, where she studied the impact of climate change on plant productivity 🌱. She completed six months of training at the Institute of Life Sciences, JNU, and has a BSc in Zoology (Hons.).

Awards

Dr. Rajashree Patnaik 🌟 has been honored with the Excellence in Research Award for the Best Research Proposal at the 5th Forum for Women in Research – QUWA, UOS 👩‍🔬. She also received the Best Poster Award at the International Conference on Stem Cells, Cancer & Biotechnology held in Goa, India, in 2016 🧬🏆. Dr. Patnaik is a two-time Gold Medalist, having earned top honors in both her MSc in Biotechnology (2011) and BSc in Zoology (Hons.) from Berhampur University, India 🎖️🎓. Her dedication to science and innovation continues to earn her recognition and inspire excellence.

Research Focus

Dr. Rajashree Patnaik primarily focuses on toxicology, stem cell research, natural product pharmacology, and anti-inflammatory interventions using both traditional and modern scientific methods. Her research spans in vitro cytotoxicity, phytochemical analysis, chemotherapeutic screening, and regenerative medicine, particularly investigating natural compounds like curcumin, oleocanthal, and herbal extracts against microbial pathogens, cancer, and inflammatory diseases. She is also active in exploring NOACs, environmental toxins, and PAR-2-mediated pathways in disease contexts like osteoarthritis and cancer. Her interdisciplinary work integrates cell biology, pharmacognosy, and biomedical applications.

Publication Top Notes

In vitro antibacterial activity, gas chromatography–mass spectrometry analysis of Woodfordia fruticosa Kurz. leaf extract and host toxicity testing with in vitro cultured …

Human dental pulp stem cells differentiation to neural cells, osteocytes and adipocytes-An in vitro study

Reconnoitering the therapeutic role of curcumin in disease prevention and treatment: Lessons learnt and future directions

An in vitro study of Ocimum sanctum as a chemotherapeutic agent on oral cancer cell-line

In vitro combinational efficacy of ceftriaxone and leaf extract of Combretum albidum G. Don against multidrug-resistant Pseudomonas aeruginosa and host-toxicity testing with …

Evaluation of geno-toxicity of methyl parathion and chlorpyrifos to human liver carcinoma cell line (HepG2)

Comparative study on toxicity of methylmercury chloride and methylmercury hydroxide to the human neuroblastoma cell line SH-SY5Y

Beyond anticoagulation: a Comprehensive Review of Non-vitamin K oral anticoagulants (NOACs) in inflammation and protease-activated receptor signaling

Cellular and Nuclear Toxicity of HgCl2 to In Vitro Grown Lymphocytes from Human Umbilical Cord Blood

Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof …

Probit analysis of comparative assays on toxicities of lead chloride and lead acetate to in vitro cultured human umbilical cord blood lymphocytes

juan iovanna | Personalized Medicine | Best Researcher Award

Posted on by sciencefather

juan iovanna | Personalized Medicine | Best Researcher Award

Prof. Dr. juan iovanna, INSERM, France

Prof. Dr. Juan Iovanna è un medico e ricercatore internazionale esperto in oncologia, specializzato nello studio del carcinoma pancreatico. Laureato e dottorato all’Università di Buenos Aires, lavora in Francia dal 1991 presso l’INSERM, dove ha raggiunto il grado di Direttore di Ricerca di Classe Eccezionale. Co-dirige il gruppo “Biologia del cancro pancreatico” al CRCM di Marsiglia e presiede il Programma G7 Cancer. Fondatore di tre start-up biotecnologiche, ha pubblicato 472 articoli con oltre 43.500 citazioni 📚. La sua missione è migliorare la prognosi del tumore pancreatico attraverso ricerca e innovazione terapeutica.

Publication Profile

orcid

Education

Prof. Dr. Juan Iovanna began his academic journey with a degree in Medicine from the University of Buenos Aires, Argentina, in 1982. Driven by a passion for biomedical research, he pursued a Ph.D. in Biomedical Sciences at the same university, which he completed in 1986. 🧬 His doctoral thesis, titled “Meccanismi di regolazione della sintesi proteica in modelli cellulari di stress,” focused on the mechanisms regulating protein synthesis in cellular stress models. 🧪 This foundational work laid the groundwork for his future contributions to medical science and molecular biology.

Experience

🔬 Prof. Dr. Juan Iovanna has built an illustrious career in cancer research. In 1991, he began as a researcher at INSERM in France and was promoted to Research Director in 1993 and again in 1998. 🚀 In 2011, he achieved the prestigious title of Directeur de Recherche de Classe Exceptionnelle (DRCE). From 2011 to 2023, he served as Vice-Director of the Marseille Cancer Research Center (CRCM) and led its Translational Medicine Department. 🧫 He also directed the “Pancreatic Cancer Biology” group from 1999 to 2023. Since 2024, he co-directs this group with Dr. Nelson Dusetti and serves as Emeritus Research Director.

Distinctions and Awards

Prof. Dr. Juan Iovanna has received numerous prestigious awards and honors throughout his career. In 2017, he was awarded the Jean Valade Prize by the Fondation de France for his outstanding contributions to biomedical research. 🌍 In 2018, he received the RAICES Award from Argentina’s Ministry of Science, Technology, and Innovation. 🇫🇷 In 2021, the French Senate honored him with a commemorative medal. In 2023, he was named Honorary Professor at the National University Arturo Jauretche (UNAJ), and in 2024, he was recognized as a Distinguished and Honorary Member of the University of Buenos Aires.

Research Focus

Prof. Dr. Juan Iovanna’s research is centered on precision oncology, with a primary focus on pancreatic ductal adenocarcinoma (PDAC). His work integrates transcriptomics, drug resistance mechanisms, redox metabolism, and multi-omics modeling to uncover novel therapeutic vulnerabilities and biomarkers. He contributes to the development of RNA signatures (like GemPred) to predict chemotherapy response, and investigates KRAS inhibition and therapy-induced senescence as pathways to reverse drug resistance. His translational studies aim to optimize personalized treatment strategies for pancreatic cancer patients, bridging molecular insights with clinical application.

Publication Top Notes

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

The PancreasView gemcitabine transcriptomic signature predicts response to gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Xiaona Ye | Herbal Medicine and Nutraceuticals | Best Researcher Award

Posted on by sciencefather

Xiaona Ye | Herbal Medicine and Nutraceuticals | Best Researcher Award

Prof. Xiaona Ye, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, China

Prof. Xiaona Ye 📚👩‍🎓 is a distinguished researcher with a strong academic background and significant professional experience 🎓. With numerous research projects 📊, publications 📄, and patents 📝, she has made notable contributions to her field. Prof. Ye’s citation index 📈 and industry-sponsored projects 💼 demonstrate her impact and relevance. As a dedicated researcher, she focuses on [specific area] 🔬, driving innovation and advancement. With a commitment to excellence, Prof. Ye is a leading figure in her field 🌟. Her work showcases her expertise and potential for continued groundbreaking research 🔍.

Publication Profile

Scopus

Education

Prof. Xiaona Ye 🎓 is a distinguished academic with a strong foundation in food science and nutrition. She earned her Ph.D. from Shandong University of Traditional Chinese Medicine, one of China’s top institutions in the field. With extensive experience in research and teaching, she has contributed significantly to food safety and functional food development. Prof. Ye has published numerous high-impact scientific papers and has been recognized for her excellence in research and innovation 🏆. Her work has advanced understanding in the health benefits of bioactive compounds, making her a respected figure in the scientific community 🌿. She continues to inspire future researchers globally.

Professional Memberships

Prof. Xiaona Ye 🤝 is an active member of several prestigious professional organizations that reflect her dedication to food science and nutrition. She is a valued member of the Institute of Food Technologists (IFT) 🌽 and the International Union of Food Science and Technology (IUFoST) 🌍. Additionally, she holds membership in the Chinese Institute of Food Science and Technology (CIFST) 🥢, where she contributes to academic development and scientific exchange. Her engagement with these societies allows her to stay at the forefront of research, collaborate internationally, and support the advancement of food safety, functional foods, and public health nutrition.

Research Focus

Prof. Xiaona Ye focuses on neuropharmacology, particularly the natural compound-based treatment of sleep disorders. Her research explores how plant-derived substances like cinnamic acid can improve sleep quality by interacting with neurotransmitter systems. In her study using parachlorophenylalanine-induced insomnia in rats, she demonstrated how cinnamic acid may restore sleep by modulating serotonin pathways. Her work bridges phytotherapy, neuroscience, and sleep medicine, contributing to safer, natural treatments for insomnia. 🌙🧪 This aligns her with categories like pharmacognosy, neuroscience, sleep research, and natural product pharmacology—areas that increasingly shape holistic approaches to mental and sleep health.

Publication Top Notes

Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award  

Mrs. Akhlesh Kumari, IFTM University Moradabad, India

Mrs. Akhlesh Kumari 📚👩‍🎓 is a dedicated academician with 8 years of teaching experience and pursuing Ph.D. in Pharmaceutical Chemistry 📊. With an M. Pharm from Central University, Rajasthan 🎓, she has published 4 research papers 📄 and filed 3 patents 📝. Her research focuses on Pharmaceutical Chemistry 🔬, contributing to the field’s advancement. Mrs. Kumari’s commitment to education and research makes her a promising figure in her field 🌟. With a citation index of 13 📈, she demonstrates her impact on the research community. Her work showcases her potential as a leading researcher 🔍.

Publication Profile

Google Scholar 

Education

Mrs. Akhlesh Kumari is a dedicated academician with a strong background in pharmaceutical sciences 📚. With 8 years of teaching experience 📝, she has established herself as a knowledgeable educator. Currently, she is pursuing her Ph.D. from IFTM University, Moradabad, India 🎓, further enhancing her expertise. She holds an M. Pharm degree in Pharmaceutical Chemistry from Central University, Rajasthan, India 🏫. Her academic pursuits demonstrate her commitment to advancing knowledge in her field 🔬. With a passion for teaching and research, Mrs. Kumari is poised to make significant contributions to pharmaceutical sciences.

Professional Memberships

Mrs. Akhlesh Kumari’s professional affiliations are currently focused on her academic and research pursuits 📚. Although she doesn’t hold any specific professional memberships 🤝, her dedication to her field is evident through her teaching and research endeavors. As she continues to grow in her career, potential memberships in professional organizations could further enhance her networking opportunities and contributions to pharmaceutical sciences 🌐. For now, her commitment to education and research remains a priority, driving her to make meaningful impacts in her field 🔬.

Research Focus

Mrs. Akhlesh Kumari focuses her research on organic synthesis, particularly the development of heterocyclic compounds and transition metal-catalyzed reactions such as Ruthenium-catalyzed oxidative annulation. Her work explores the design of novel antimicrobial agents, including thymol-derived chalcones and benzotriazoles, integrating computational studies to understand structure-activity relationships. This research is crucial in the development of new pharmaceutical compounds with potential biological activity. Her studies bridge synthetic organic chemistry and medicinal chemistry, targeting antimicrobial resistance and innovative drug discovery strategies.

Publication Top Notes

Ruthenium‐catalyzed oxidative annulation of anilines using benzothiazole as a removable directing group

Synthesis, computational studies of new thymol derived chalcones and their benzotriazoles as antimicrobial agents

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Yan Zhang | Medicinal Chemistry | Best Researcher Award  

Assoc. Prof. Dr. Yan Zhang, Hospital of Stomatology, Jilin University, China

Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, specializing in innovative dental implant materials, particularly magnesium-based alloys. She is currently a researcher at the Hospital of Stomatology, Jilin University, focusing on biocompatible implant development. With over 10 SCI-indexed publications, her work on the Nd-modified alloy ZNdK610 shows enhanced osteogenic potential. Dr. Zhang has completed three research projects and is actively pursuing translational research and industry collaborations. Though she has no patents or books yet, her pioneering research continues to push boundaries in implant material science.

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, with a research focus on innovative implant materials, particularly the application of magnesium alloys 🧪🦷. As a dedicated researcher at the Hospital of Stomatology, Jilin University, Dr. Zhang is actively involved in developing biocompatible materials to improve dental implant performance. Her work aims to enhance osseointegration and long-term implant success through advanced biomaterials 🔬💡. With over 10 SCI-indexed publications, she has significantly contributed to the field of dental biomaterials, driving progress in implant technology and patient care 📚👩‍⚕️.

Professional Memberships

Assoc. Prof. Dr. Yan Zhang is currently not affiliated with any professional memberships or academic societies ❌📋. Despite this, her dedication to advancing dental implant technology through independent research remains unwavering 🔬🦷. Her work at the Hospital of Stomatology, Jilin University, continues to make meaningful contributions to the field, particularly in the development of magnesium alloy-based implant materials ⚙️🧪. While she may not hold formal memberships, her impactful research, numerous SCI-indexed publications, and commitment to scientific innovation speak volumes about her professional standing and influence in the stomatology community 📖💼.

Research Focus

Assoc. Prof. Dr. Yan Zhang specializes in Periodontal Regeneration and Tissue Engineering. Their research primarily focuses on how biological factors like Concentrated Growth Factor (CGF) exudate influence the healing and proliferation of human periodontal ligament cells, especially under inflammatory conditions such as those involving TNF-α (tumor necrosis factor-alpha). This work is crucial in understanding and improving treatments for periodontal diseases by promoting tissue repair and regeneration. Dr. Zhang’s research bridges cell biology, inflammation, and regenerative medicine to develop innovative therapies for oral health.

Publication Top Notes

Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-α